Abstract

This retrospective analysis aimed to characterize the demographic and clinical features of patients diagnosed with systemic lupus erythematosus (SLE). A total of [insert number] patients were included in the study, with the largest proportion (34.3%) falling within the age range of 31 to 40 years. Female predominance was evident, comprising 91 patients (86.7%) of the cohort. Joint involvement emerged as the most prevalent manifestation, affecting 80 patients (76.2%), whereas cardiac involvement was the least frequent, observed in 7 patients (6.7%). A significant majority (95.2%) of patients exhibited positive antinuclear antibody (ANA) test results, while more than half (68.6%) tested positive for Anti-double stranded DNA (Anti-dsDNA). The primary medications reported were hydroxychloroquine, prescribed to 104 patients (99%), and steroids, administered to 89 patients (84.8%). This analysis provides valuable insights into the demographic composition and clinical presentation of SLE patients, underscoring the predominance of females and highlighting common manifestations and treatment modalities.